Status:
COMPLETED
Physiopathology of Lower Cortical Activation in COPD Patients: Contribution of Cortical Neuromodulation
Lead Sponsor:
5 Santé
Conditions:
Physiology
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Patients with COPD have lower cortical activation and higher cortical inhibitory levels. The purpose of this study is to test the reversibility the lower cortical activation by counterbalancing the in...
Detailed Description
Chronic obstructive pulmonary disease (COPD) patients exhibit not only respiratory symptoms but also a peripheral muscular weakness. This weakness is characterized by a loss in strength, harmful for t...
Eligibility Criteria
Inclusion
- Health insurance
- Patients : COPD Gold II-IV
- Patients : No rehabilitation since at least 1 yrs
- Control : sedentary (\< 9 Voorips)
Exclusion
- Pregnant women
- Seizures
- Unable to give written consent
- Metalic object above shoulders
- Dermatological issue concerning surface electrodes
- Drugs influencing central nervous system
- Caffeine consumption \> 4 coffee / day
- Neurological disorders
- Patients : recent exacerbation (\< 4 weeks)
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03368703
Start Date
June 1 2017
End Date
June 30 2018
Last Update
January 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques du Souffle
Lodève, Herault, France, 34700